Free Trial
→ DeepSeek’s Clear and Present Danger (From Brownstone Research) (Ad) Buy CRL Stock  Free CRL Stock Alerts

Charles River Laboratories International (CRL) SEC Filings & 10K Form

Charles River Laboratories International logo
$112.14 +3.14 (+2.88%)
As of 10:36 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Recent Charles River Laboratories International SEC Filings

Export to Excel
DateFilerForm TypeView
04/17/2025
8:35 AM		BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SCHEDULE 13G/A
04/02/2025
7:00 AM		Charles River Laboratories International (Filer)
Form DEF 14A
04/02/2025
7:06 AM		Charles River Laboratories International (Filer)
Form ARS
02/26/2025
3:18 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:36 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:38 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:41 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2025
3:30 PM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2025
11:36 AM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
02/19/2025
8:07 AM		Charles River Laboratories International (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/19/2025
6:19 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/03/2025
4:17 PM		Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:22 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:25 PM		Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/03/2025
3:27 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/14/2025
7:04 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
3:42 PM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2024
5:21 PM		Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
4:31 PM		BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
11/08/2024
9:52 AM		Charles River Laboratories International (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G
11/07/2024
3:23 PM		Charles River Laboratories International (Subject)
WALLMAN RICHARD F (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/06/2024
8:16 AM		Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2024
6:21 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2024
2:24 PM		BlackRock, Inc. (Filed by)
Charles River Laboratories International (Subject)
Form SC 13G/A
08/13/2024
3:17 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/12/2024
3:13 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/08/2024
12:34 PM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/07/2024
8:15 AM		Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/07/2024
6:21 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/04/2024
3:46 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/04/2024
3:17 PM		Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/03/2024
3:37 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
7:05 PM		Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
7:18 PM		Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/30/2024
6:56 PM		Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4/A
05/30/2024
7:02 PM		Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4/A
05/30/2024
6:47 PM		Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4/A
05/30/2024
5:58 PM		Charles River Laboratories International (Issuer)
FOSTER JAMES C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:51 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:46 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:48 PM		Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
The Trump Dump is starting; Get out of stocks now? (Ad)

The first 365 days of the Trump presidency… Will be the best time to get rich in American history.

If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a
05/29/2024
4:34 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:38 PM		Charles River Laboratories International (Issuer)
Pease Flavia (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:08 PM		Charles River Laboratories International (Issuer)
Creamer Victoria L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2024
4:10 PM		Charles River Laboratories International (Issuer)
Knell Michael Gunnar (Reporting)
Form 4/A
05/29/2024
3:05 PM		Charles River Laboratories International (Filer)
Form SD
Specialized Disclosure Report  
05/28/2024
4:42 PM		Barbo William D (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:25 PM		Charles River Laboratories International (Issuer)
Girshick Birgit (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:29 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2024
4:32 PM		Charles River Laboratories International (Issuer)
Parisotto Shannon M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/16/2024
3:35 PM		Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:24 PM		Andrews Nancy C (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
6:30 PM		Charles River Laboratories International (Issuer)
WILSON VIRGINIA M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:47 PM		Charles River Laboratories International (Issuer)
Thompson Craig B. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:52 PM		Charles River Laboratories International (Issuer)
MACKAY MARTIN (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:38 PM		BERTOLINI ROBERT J (Reporting)
Charles River Laboratories International (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:42 PM		Charles River Laboratories International (Issuer)
WALLMAN RICHARD F (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:27 PM		Charles River Laboratories International (Issuer)
MASSARO GEORGE (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:30 PM		Charles River Laboratories International (Issuer)
Llado George Sr. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2024
4:34 PM		Charles River Laboratories International (Issuer)
Kemps-Polanco Reshema (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/14/2024
3:49 PM		Charles River Laboratories International (Issuer)
LaPlume Joseph W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/10/2024
10:30 AM		Charles River Laboratories International (Subject)
LaPlume Joseph W (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/09/2024
3:20 PM		Charles River Laboratories International (Filer)
Form S-3ASR
05/09/2024
8:17 AM		Charles River Laboratories International (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/09/2024
6:31 AM		Charles River Laboratories International (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/24/2024
6:30 AM		Charles River Laboratories International (Filer)
Form DEFA14A
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NYSE:CRL) was last updated on 4/24/2025 by MarketBeat.com Staff
From Our Partners
Virtually Limitless Energy?
A radical energy breakthrough could change everything. Scientists at MIT and a stealth startup may have discov...
Stansberry Research | Sponsored
A Biotech Power Move? This company is leading the charge in developing advanced antiviral therapies—watch closely!
With a revolutionary antiviral drug, this company is in a great position to build shareholder value as this ti...
Smallcaps Daily | Sponsored
Musk’s AI Masterplan – Our #1 AI Stock to Buy Now
Did Elon Musk just set the stage for the next AI stock explosion? One 30-year Wall Street veteran thinks so...
Behind the Markets | Sponsored
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “g...
Golden Portfolio | Sponsored
Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...
Porter & Company | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
URGENT: This Altcoin Opportunity Won’t Wait – Act Now
The July 23rd Crypto Trigger Could Mark the Beginning of Bitcoin’s Next Big Move Bitcoin’s early 2024 ETF r...
Crypto Swap Profits | Sponsored
Do this Before Elon's Reveal on April 23rd
Elon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...
Brownstone Research | Sponsored